Cfo & Vp Finance
Sirna Therapeutics (Company Moved San Francisco And Acquired By Merck In 2006)
Boulder, Colorado
Responsible for all financial reporting, planning and accounting operations for this publicly traded, development stage bio-pharmaceutical company. In addition, managed and oversaw risk management, human resources, IT and investor relations. • Instrumental in raising over $281 million through multiple equity financings including an IPO, follow-on public and private offerings, as well as debt and equity deals through joint ventures and collaborations with large multinational pharmaceutical corporations.• Authored external public financial reports, including SEC Forms 10-K, 10-Q, S-3, Proxy, 8-K filings and all monthly internal executive financial reports.• Presented financial results to executive management and the Board of Directors.• Designed and implemented the operational infrastructure for finance, accounting and human resources, from the start-up stage, through growth stage, and ultimately a public company employing up to 130 scientists, researchers and administrative staff.• Responsible for risk management. • Analyzed, negotiated and implemented numerous benefit packages for employees, including health, life and disability insurance, flexible spending plan, stock option plan, employee stock purchase plan and 401(k) plan.